![](/img/cover-not-exists.png)
Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing
Kay Stubenrauch, Uwe Wessels, Herbert Birnboeck, Francisco Ramirez, Angelika Jahreis, Julia SchleypenVolume:
32
Year:
2010
Language:
english
Pages:
13
DOI:
10.1016/j.clinthera.2010.07.021
File:
PDF, 2.30 MB
english, 2010